Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stereotactic Body Radiation Therapy to the Prostate Fossa: Phase I Dose Escalation Study

NCT01923506 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT01923506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01923506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stereotactic Body Radiation Therapy to the Prostate Fossa: Phase I Dose Escalation Study
Lead sponsor
City of Hope Medical Center
Phase
Phase 1
Overall status
Active, not recruiting
Start date
November 25, 2013
Completion date
June 28, 2027
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent prostate cancer, stage i prostate cancer, stage iia prostate cancer, stage iib prostate cancer, stage iii prostate cancer